Interestingly, we observed also 4PD binding to lineage negative CD34+ckit+ hematopoietic precursors in the bone marrow, spleen and tumor suggesting that this platform might be used to modulate gene expression on HSPCs. The gene discussed is CD34; the disease is neoplasm.